Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Fujimi

Showing results (21-30 of 69) with videos related to

Pageof 7
Sort By:
QJM : Monthly Journal of the Association of Physicians|October 1, 2021
Refractory pneumothorax secondary to COVID-19 treated by autologous blood patch pleurodesisY Mitsuyama, S Tanaka, A Ike, et al.
American Journal of Nephrology|January 1, 1991
Effects of the methylprednisolone pulse therapy on renal functionT Sakemi, M Yamaguchi, S Fujimi, et al.
Clinical Nephrology|March 1, 1982
Comparison of the immediate hemodynamic effects of SQ 14225 (Captopril) and [Sar1, Ileu8] angiotensin II in patients with dialysis resistant hypertensionK Iseki, K Onoyama, S Fujimi, et al.
The Japanese Journal of Surgery|December 1, 1980
Occurrence of ANTI-AHLG in renal transplant patients on AHLG (anti-human lymphocyte globulin)K Konomi, T Ohta, K Toyoda, et al.
Clinical Nephrology|June 1, 1990
Hemodynamic and volume changes by recombinant human erythropoietin (rHuEPO) in the treatment of anemic hemodialysis patientsK Hori, K Onoyama, K Iseki, et al.
Nephron|January 1, 1984
Autologous immune complex nephritis in streptozotocin-induced diabetic ratsS Okuda, Y Oh, K Onoyama, et al.
International Urology and Nephrology|January 1, 1995
Idiopathic sudden sensorineural hearing loss in patients undergoing long-term haemodialysisY Makita, S Osato, K Onoyama, et al.
American Journal of Nephrology|January 1, 1988
Does 1 alpha(OH)D3 treatment affect blood pressure levels in maintenance hemodialysis patients?K Shimamatsu, K Onoyama, S Fujimi, et al.
Kidney International|February 1, 1986
Adriamycin-induced nephropathy as a model of chronic progressive glomerular diseaseS Okuda, Y Oh, H Tsuruda, et al.
Clinical Nephrology|December 1, 1981
Captopril (SQ 14225) clearance during hemodialysis treatmentH Hirakata, K Onoyama, K Iseki, et al.
Pageof 7

Showing results (21-30 of 69) with videos related to

Sort By:
Pageof 7
QJM : Monthly Journal of the Association of Physicians|October 1, 2021
Refractory pneumothorax secondary to COVID-19 treated by autologous blood patch pleurodesisY Mitsuyama, S Tanaka, A Ike, et al.
American Journal of Nephrology|January 1, 1991
Effects of the methylprednisolone pulse therapy on renal functionT Sakemi, M Yamaguchi, S Fujimi, et al.
Clinical Nephrology|March 1, 1982
Comparison of the immediate hemodynamic effects of SQ 14225 (Captopril) and [Sar1, Ileu8] angiotensin II in patients with dialysis resistant hypertensionK Iseki, K Onoyama, S Fujimi, et al.
The Japanese Journal of Surgery|December 1, 1980
Occurrence of ANTI-AHLG in renal transplant patients on AHLG (anti-human lymphocyte globulin)K Konomi, T Ohta, K Toyoda, et al.
Clinical Nephrology|June 1, 1990
Hemodynamic and volume changes by recombinant human erythropoietin (rHuEPO) in the treatment of anemic hemodialysis patientsK Hori, K Onoyama, K Iseki, et al.
Nephron|January 1, 1984
Autologous immune complex nephritis in streptozotocin-induced diabetic ratsS Okuda, Y Oh, K Onoyama, et al.
International Urology and Nephrology|January 1, 1995
Idiopathic sudden sensorineural hearing loss in patients undergoing long-term haemodialysisY Makita, S Osato, K Onoyama, et al.
American Journal of Nephrology|January 1, 1988
Does 1 alpha(OH)D3 treatment affect blood pressure levels in maintenance hemodialysis patients?K Shimamatsu, K Onoyama, S Fujimi, et al.
Kidney International|February 1, 1986
Adriamycin-induced nephropathy as a model of chronic progressive glomerular diseaseS Okuda, Y Oh, H Tsuruda, et al.
Clinical Nephrology|December 1, 1981
Captopril (SQ 14225) clearance during hemodialysis treatmentH Hirakata, K Onoyama, K Iseki, et al.
Pageof 7